by admin | Apr 19, 2024 | Article
On April 14, Evusheld – the only pre-exposure long-acting monoclonal antibody for COVID-19 prevention – was authorized by Health Canada and recently supported with broad recommendations for use in immune-compromised Canadians by the Canadian Agency...
by admin | Apr 19, 2024 | Article
UM clinician scientist Dr. Lily Lim is using artificial intelligence (AI) to better recognize lupus in patients. Known as “the disease with a thousand faces” symptoms vary from person to person. Lab tests aren’t always conclusive. The autoimmune disorder is infamously...
by admin | Apr 19, 2024 | Article
https://www.lupuscanada.org/wp-content/uploads/Immune-Compromised-Canadians-and-COVID-19.pdf
by admin | Apr 19, 2024 | Article
https://19tozero.notion.site/UPDATED-Video-Everything-You-Need-To-Know-About-Evusheld-in-15-Minutes-Or-Less-with-Dr-Jia-Hu-33f3925dd7dc470d806be940a3ce1b95
by admin | Apr 19, 2024 | Article
November 9, 2023 – SAPHNELO data shows patients are more likely to achieve and sustain remission in systemic lupus erythematosus compared to standard therapy alone. For more information, please...
